PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients

MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)—- $PHAS #ARDS–PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients